505 |
0 |
0 |
|t In memorium : Gideon Rodan M.D. Ph.D. : contributions to bone biology and global health /
|r Dwight A. Towler and Jack Martin --
|t Editorial : skeletal biology and skeletal medicine /
|r Mone Zaidi --
|t PTHrP and skeletal development /
|r Henry M. Kronenberg --
|t Regulating bone growth and development with bone morphogenetic proteins /
|r Phoebe S. Leboy --
|t BMP and BMP inhibitors in bone /
|r Vicki Rosen --
|t BMP signaling and skeletogenesis /
|r Xuelin Li and Xu Cao --
|t Function of BMPs and BMP antagonists in adult bone /
|r Etsuko Abe --
|t Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva /
|r Frederick S. Kaplan, Jennifer Fiori, Lourdes Serrano De La Pena, Jaimo Ahn, Paul C. Billings and Eileen M. Shore --
|t Hypoxia and HIF-1[alpha] in chondrogenesis /
|r Ernestina Schipani --
|t Cellular and molecular mechanisms of synovial joint and articular cartilage formation /
|r Maurizio Pacifici, Eiki Koyama, Yoshihiro Shibukawa, Changshan Wu, Yoshihiro Tamamura, Motomi Enomoto-Iwamoto and Masahiro Iwamoto --
|t Multiple roles of Hoxc8 in skeletal development /
|r Aster H. Juan, Haiyan Lei, Prerna Bhargava, Marielle Lebrun and Frank H. Ruddle --
|t Osteoclasts and integrins /
|r Steven L. Teitelbaum --
|t Regulation of osteoclast differentiation /
|r G. David Roodman --
|t M-CSF, c-Fms, and signaling in osteoclasts and their precursors /
|r F. Patrick Ross --
|t Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation /
|r Donald A. Glass II and Gerard Karsenty --
|t Inhibition of ATF4 transcriptional activity by FIAT/[gamma]-taxilin modulates bone mass accrual /
|r Vionnie W. C. Yu, Claude Gauthier and Rene St-Arnaud --
|t Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/ NF-[kappa]B signaling /
|r Michael P. Whyte --
|t The regulation of cathepsin K gene expression /
|r Bruce R. Troen --
|t Direct and indirect estrogen actions on osteoblasts and osteoclasts /
|r Alberta Zallone --
|t Molecular mechanism of the life and death of the osteoclast /
|r Sakae Tanaka, Tsuyoshi Miyazaki, Akira Fukuda, Toru Akiyama, Yuho Kadono, Hidetoshi Wakeyama, Shinjiro Kono, Shinya Hoshikawa, Masaki Nakamura, Yasushi Ohshima, Atsuhiko Hikita, Ichiro Nakamura and Kozo Nakamura --
|t Understanding parathyroid hormone action /
|r Nicola C. Partridge, Xin Li and Ling Qin --
|t New insights into the mechanisms involved in the pleiotropic actions of 1,25dihydroxyvitamin D[subscript 3] /
|r Sylvia Christakos, Puneet Dhawan, Qi Shen, Xiaorong Peng, Bryan Benn and Yan Zhong --
|t Mechanism of vitamin D receptor action /
|r Marie B. Demay --
|t Role of Connexin43 in osteoblast response to physical load /
|r Susan K. Grimston, Joanne Screen, Jennifer H. Haskell, Dong Jin Chung, Michael D. Brodt, Matthew J. Silva and Roberto Civitelli --
|t Interactive effect of interleukin-6 and prostaglandin E[subscript 2] on osteoclastogenesis via the OPG/RANKL/RANK system /
|r Xin-Hua Liu, Alexander Kirschenbaum, Shen Yao and Alice C. Levine --
|t Does TNF have anti-osteoclastogenic actions? /
|r Jameel Iqbal --
|t Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression /
|r Veronica Garcia-Palacios, Ho Yeon Chung, Sun Jin Choi, Noriyoshi Kurihara, Jun Won Lee, Lori A. Ehrlich, Robert Collins and G. David Roodman --
|t Bone cell precursors and the pathophysiology of bone loss /
|r Harry C. Blair and Jill L. Carrington --
|t Autosomal-dominant pseudohypoparathyroidism type Ib is caused by different microdeletions within or upstream of the GNAS locus /
|r Harald Juppner, Agnes Linglart, Leopold F. Frohlich and Murat Bastepe --
|t Estrogen regulation of immune cell bone interactions /
|r M. Neale Weitzmann and Roberto Pacifici --
|t Autoimmunity and bone /
|r Edward M. Schwarz, R. John Looney, M. Hicham Drissi, Regis J. O'Keefe, Brendan F. Boyce, Lianping Xing and Christopher T. Ritchlin --
|t Nonsteroid immune modulators and bone disease /
|r Ronald Tamler and Solomon Epstein --
|t Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS /
|r George Pan, Zhen Yang, Scott W. Ballinger and Jay M. McDonald --
|t TSH and bone loss /
|r Li Sun, Terry F. Davies, Harry C. Blair, Etsuko Abe and Mone Zaidi --
|t Bone destruction in multiple myeloma /
|r Toshio Matsumoto and Masahiro Abe --
|t Osteogenic regulation of vascular calcification /
|r Dwight A. Towler, Jian-Su Shao, Su-Li Cheng, Joyce M. Pingsterhaus and Arleen P. Loewy --
|t The role of OPG/TRAIL complex in multiple myeloma : the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease /
|r Giacomina Brunetti, Silvia Colucci, Rita Rizzi, Giorgio Mori, Graziana Colaianni, Angela Oranger, Alberta Zallone, Vincenzo Liso and Maria Grano --
|t Restoration of bone mass in Hpg mouse by preoptic area grafting /
|r Gopalan Rajendren, Hang Zhou, Baljit S. Moonga, Mone Zaidi and Li Sun --
|t IL-7 drives T cell-mediated bone loss following ovariectomy /
|r Michaela Robbie-Ryan, Roberto Pacifici and M. Neale Weitzmann --
|t Stem cells and tissue engineering : past, present, and future /
|r Julia M. Polak and Anne E. Bishop --
|t Bisphosphonates : from bench to bedside /
|r R. Graham G. Russell --
|t Novel targets and therapeutics for bone loss /
|r Ronald N. Margolis and Sunil J. Wimalawansa --
|t Advanced imaging assessment of bone quality /
|r Harry K. Genant and Yebin Jiang --
|t Bone strength : current concepts /
|r Charles H. Turner --
|t Future anti-catabolic therapeutic targets in bone disease /
|r Brendan F. Boyce, Lianping Xing, Zhenqiang Yao, William C. Shakespeare, Yihan Wang, Chester A. Metcalf III, Raji Sundaramoorthi, David C. Dalgarno, John D. Igliucci and Tomi K. Sawyer --
|t Mechanisms involved in skeletal anabolic therapies /
|r T. J. Martin, J. M. W. Quinn, M. T. Gillespie, K. W. Ng, M. A. Karsdal and N. A. Sims --
|t Misconceptions about calcimimetics /
|r E. F. Nemeth --
|t Osteoblastic activation in the hematopoietic stem cell niche /
|r Laura M. Calvi --
|t Circulating cells with osteogenic potential /
|r Sundeep Khosla and Gutti Z. Eghbali-Fatourechi --
|t The pericellular matrix as a transducer of biomechanical and biochemical signals in articular cartilage /
|r Farshid Guilak, Leonidas G. Alexopoulos, Maureen L. Upton, Inchan Youn, Jae Bong Choi, Li Cao, Lori A. Setton and Mansoor A. Haider --
|t Clinical biophysics : the promotion of skeletal repair by physical forces /
|r Roy K. Aaron, Deborah Mck. Ciombor, Shuo Wang and Bruce Simon --
|t COX-2 has a critical role during incorporation of structural bone allografts /
|r Regis J. O'Keefe, Prarop Tiyapatanaputi, Chao Xie, Tian Fang Li, Chris Clark, Michael J. Zuscik, Di Chen, Hicham Drissi, Edward Schwarz and Xinping Zhang --
|t The effect of anti-TNF-[alpha] therapy on spinal bone mineral density in patients with Crohn's disease /
|r Michael Pazianas, Andrew D. Rhim, Andrew M. Weinberg, Chinyu Su and Gary R. Lichtenstein --
|t Bone remodeling in health and disease : lessons from mathematical modeling /
|r Svetlana V. Komarova --
|t Modeling of serum C-telopeptide levels with daily and monthly oral ibandronate in humans /
|r Mone Zaidi, Solomon Epstein and Keith Friend --
|t NFATc1 : a novel anabolic therapeutic target for osteoporosis /
|r Hyeonju Yeo, Jay M. McDonald and Majd Zayzafoon --
|t Mechanical loading differentially regulates membrane-bound and soluble RANKL availability in MC3T3-El cells /
|r Dae Won Kim, Hahn-Jun Lee, Jaime A. Karmin, Se Eun Lee, Seong-Sil Chang, Ben Tolchin, Shiphin Lin, Sam K. Cho, Anthony Kwon, Jae Mok Ahn and Francis Young-In Lee.
|